Chris Moreau
Algemeen Directeur bij ALGERNON PHARMACEUTICALS INC.
Vermogen: 93 047 $ op 30-04-2024
Actieve functies van Chris Moreau
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALGERNON PHARMACEUTICALS INC. | Directeur/Bestuurslid | 13-05-2020 | - |
| Algemeen Directeur | 01-03-2018 | - | |
| Investor Relations Contact | - | - |
Loopbaan van Chris Moreau
Eerdere bekende functies van Chris Moreau
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| QUEBEC PEGMATITE HOLDINGS CORP. | Directeur/Bestuurslid | 08-02-2019 | 26-11-2020 |
| President | 08-02-2019 | 24-07-2019 | |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Directeur/Bestuurslid | 02-06-2011 | 21-04-2016 |
| Algemeen Directeur | 01-02-2007 | 21-04-2016 | |
| Investor Relations Contact | 31-03-2011 | 21-04-2016 | |
| President | 01-02-2007 | 21-04-2016 | |
Nash Pharmaceuticals, Inc.
 Nash Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nash Pharmaceuticals, Inc. engages in the research and development of repurposed therapeutic drugs and pharmaceutical products. Its focus areas include non-alcoholic steatohepatitis, chronic kidney disease, and inflammatory bowel disease. The company is headquartered in Vancouver, Canada. | Algemeen Directeur | - | - |
| Advansis Capital Corp. | President | - | - |
Statistieken
Internationaal
| Canada | 6 |
Operationeel
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
| President | 3 |
Sectoraal
| Health Technology | 3 |
| Commercial Services | 2 |
| Electronic Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ALGERNON PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Commercial Services |
| Advansis Capital Corp. | |
First Responder Technologies, Inc.
 First Responder Technologies, Inc. Aerospace & DefenseElectronic Technology First Responder Technologies, Inc. is in the process of exploring business opportunities. The company was founded on January 27, 2017 and is headquartered in Vancouver, Canada. | Electronic Technology |
Nash Pharmaceuticals, Inc.
Nash Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nash Pharmaceuticals, Inc. engages in the research and development of repurposed therapeutic drugs and pharmaceutical products. Its focus areas include non-alcoholic steatohepatitis, chronic kidney disease, and inflammatory bowel disease. The company is headquartered in Vancouver, Canada. | Health Technology |
- Beurs
- Insiders
- Chris Moreau
- Ervaring